Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Plant Foods Hum Nutr ; 79(1): 98-105, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38085440

RESUMEN

A water-soluble polysaccharide (EP) was purified from edible algae Enteromorpha prolifera. Gel permeation chromatography (GPC), ion chromatography (IC), and fourier transform infrared (FT-IR) were performed to characterize its structure. EP was defined as a low molecular weight (6625 Da) composed of rhamnose, glucose, glucuronic acid, xylose, galactose, arabinose, and mannose. Moreover, it was a sulfated polysaccharide with a degree of substitution (DS) of 1.48. Then, the high-fat diet/streptozotocin (HFD/STZ) induced diabetic mouse model was established to support evidence for a novel hypoglycemic mechanism. Results showed that blood glucose (47.32%), liver index (7.65%), epididymal fat index (16.86%), serum total cholesterol (26.78%) and triglyceride (37.61%) in the high-dose EP (HEP) group were significantly lower than those in the HFD group. Noticeably, the content of liver glycogen in the HEP group was significantly higher (62.62%) than that in the HFD group, indicating the promotion of glycogen synthesis. These beneficial effects were attributed to significantly increased protein kinase B (AKT) phosphorylation and its downstream signaling response. Further studies showed that diabetic mice exhibited excessive O-GlcNAcylation level and high expression of O-linked ß-D-N-acetylglucosamine transferase (OGT), which were decreased by 62.21 and 30.43% in the HEP group. This result suggested that EP had a similar effect to OGT inhibitors, which restored AKT phosphorylation and prevented pathoglycemia. This work reveals a novel hypoglycemic mechanism of EP, providing a theoretical basis for further studies on its pharmacological properties in improvement of T2DM.


Asunto(s)
Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 2 , Algas Comestibles , Ulva , Animales , Ratones , Diabetes Mellitus Tipo 2/prevención & control , Proteínas Proto-Oncogénicas c-akt , Sulfatos , Diabetes Mellitus Experimental/tratamiento farmacológico , Espectroscopía Infrarroja por Transformada de Fourier , Hipoglucemiantes/farmacología , Polisacáridos/farmacología
2.
Food Funct ; 9(8): 4376-4383, 2018 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-30051131

RESUMEN

Enteromorpha prolifera is an edible alga and previous studies have indicated that E. prolifera polysaccharide (EP) attenuates non-alcoholic fatty liver disease (NAFLD) in high-fat diet rats. Hydrogen sulfide (H2S) has recently been found to exert many physiological effects. The purpose of this study was to evaluate whether EP prevents NAFLD via regulation of H2S production. EP was orally administered to high-fat diet rats for 5 weeks. Treatment with EP (200 mg per kg body weight per d) significantly increased the serum H2S level and reduced the serum triglyceride level (p < 0.05) in rats fed a high-fat diet. These effects were similar to those observed with NaHS, a H2S donor. Real-time PCR and western blotting analysis revealed that EP significantly upregulated hepatic mRNA and protein expression of cystathionine-ß-synthase, which is the enzyme responsible for H2S production. These results indicate that EP decreases the serum TG level by increasing H2S production, suggesting that EP may be beneficial for the treatment of NAFLD and may reduce the risk of cardiovascular disease.


Asunto(s)
Sulfuro de Hidrógeno/sangre , Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Polisacáridos/administración & dosificación , Ulva/química , Verduras/química , Animales , Cistationina betasintasa/metabolismo , Dieta Alta en Grasa/efectos adversos , Femenino , Humanos , Enfermedad del Hígado Graso no Alcohólico/sangre , Enfermedad del Hígado Graso no Alcohólico/etiología , Extractos Vegetales/química , Polisacáridos/química , Ratas , Ratas Sprague-Dawley , Triglicéridos/sangre
3.
Drug Deliv ; 22(4): 475-86, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-24321014

RESUMEN

Herbal drugs have been used for thousands of years in the east and have had a recent resurgence in popularity among consumers in the west. However, most of herbal drug are poorly soluble and have hydrophobic properties and poor distribution, leading to reduced bioavailability and hence decreased treatment efficacy, requiring repeated administration or increased dose. In the past few decades, considerable attention has been focused on the development of self-emulsifying drug delivery system (SEDDS) for herbal drugs. SEDDS is isotropic and thermodynamically stable solutions consisting of oil, surfactant, co-surfactant and drug that can spontaneously form oil-in-water micro/nanoemulsion when mixed with water under gentle stirring. The formulation can be a viable alternative to classical formulations to take advantage of their lipophilic nature and to solve their problems of poor solubility, poor bioavailability, low oral absorption and instability. The mechanism of self-emulsification, solubility studies, construction of phase diagram, optimization and characterization of herbal drugs-loaded SEDDS formulation and in situ absorption evaluation of herbal drugs in rat intestine are presented in our article.


Asunto(s)
Sistemas de Liberación de Medicamentos , Preparaciones de Plantas/administración & dosificación , Plantas Medicinales/química , Tensoactivos/química , Animales , Disponibilidad Biológica , Química Farmacéutica , Emulsiones , Absorción Intestinal , Masculino , Aceites/química , Preparaciones de Plantas/farmacocinética , Ratas , Ratas Sprague-Dawley , Solubilidad , Termodinámica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA